ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
1,27
-0,005
( -0,39% )
Aktualisiert: 13:53:19

Provexis (PXS) Aktie

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
1,27
( -0,39% )
Gebot
1,25
Fragen
1,30
Volumen
4.869.395
1,25 Tagesbereich 1,32
0,55 52-Wochen-Bereich 1,55
Marktkapitalisierung
Handelsende
1,275
Handelsbeginn
1,25
Letzte Trade
108545
@
1.25
(O)
Letzter Handelszeitpunkt
16:10:00
Finanzvolumen
62.854p
VWAP
1,2908
Durchschnittliches Volumen (3 Mio.)
1.686.236p
Ausgegebene Aktien
2.345.891.239
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-46,55
Gewinn pro Aktie (EPS)
-0
Erlöse (LTM)
871,27k
Nettogewinn (LTM)
-603,8k

Über Provexis

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated wit... Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product. The company sells its products through e-commerce website and distributors. Provexis plc was founded in 1999 and is based in Reading, the United Kingdom. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Hauptsitz
Reading, United Kingdom
Gegründet
1999
Provexis is listed in the Healthcare sector of the Londoner Börse with ticker PXS. The last closing price for Provexis was 1,28p. Over the last year, Provexis shares have traded in a share price range of 0,55p to 1,55p.

Provexis currently has 2.345.891.239 shares in issue. The market capitalisation of Provexis is £29,79 million. Provexis has a price to earnings ratio (PE ratio) of -46.55.

PXS Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.021.61.251.321.115266601.25DE
40.1715.45454545451.11.320.9416898441.09710018DE
120.1715.45454545451.11.320.9215952671.06296837DE
260.38543.50282485880.8851.550.8529454051.14996828DE
520.4758.750.81.550.5517149171.01866027DE
1560.771540.51.550.440511810160.78704742DE
2600.272711.550.440510764600.79700364DE

PXS - Frequently Asked Questions (FAQ)

What is the current Provexis share price?
The current share price of Provexis is 1,27p
How many Provexis shares are in issue?
Provexis has 2.345.891.239 shares in issue
What is the market cap of Provexis?
The market capitalisation of Provexis is GBP 29,79M
What is the 1 year trading range for Provexis share price?
Provexis has traded in the range of 0,55p to 1,55p during the past year
What is the PE ratio of Provexis?
The price to earnings ratio of Provexis is -46,55
What is the cash to sales ratio of Provexis?
The cash to sales ratio of Provexis is 32,71
What is the registered address of Provexis?
The registered address for Provexis is 2 Blagrave Street, Reading, Berkshire, RG1 1AZ
What is the Provexis website address?
The website address for Provexis is www.provexis.com
Which industry sector does Provexis operate in?
Provexis operates in the Pharmaceuticals sector

PXS Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen